DRUG-PRICING

DRUG-PRICING

Genentech executive Fritz Bittenbender: Beware political soundbites

As Election Day draws near, the biotech industry is grappling with pressing issues that could significantly impact its future. Among the leading companies in this sector, Genentech stands out for its commitment to advancing health equity and fostering inclusive research. At the forefront of this effort is Fritz Bittenbender, the Senior Vice President and Head of Genentech Public Affairs & Access..

DRUG-PRICING

Understanding PMBs' role and impact on drug pricing

The Hidden Players Behind High Prescription Costs Pharmacy benefit managers (PBMs) are pivotal players in the pharmaceutical supply chain, influencing drug pricing, patient access, and healthcare sp..